Lower GI 2017

MSKCC-Trial (randomized phase II)

MRI-staged T2-3 N0 or T any N+

FOLFOX/ CAPOX (16-18 weeks)

N O M

Signi- ficant response

RT 50.4 Gy + 5-FU/Cape

R E S T A G I N G

R

No signi- ficant response

T M E

FOLFOX/ CAPOX (16-18 weeks)

RT 50.4 Gy + 5-FU/Cape